Zheng Xing Xing Ye Ri Bao·2025-09-01 08:44Market Performance - The biopharmaceutical sector increased by 2.93% on September 1, with Zhixiang Jintai leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] Top Gainers in Biopharmaceutical Sector - Zhixiang Quantai (688443) closed at 37.02, up 12.11% with a trading volume of 162,600 shares and a transaction value of 591 million [1] - Yiqiao Shenzhou (301047) closed at 82.09, up 10.65% with a trading volume of 56,000 shares and a transaction value of 450 million [1] - Kangchen Pharmaceutical (603590) closed at 61.79, up 10.01% with a trading volume of 78,600 shares and a transaction value of 480 million [1] - Changchun High-tech (000661) closed at 113.37, up 10.00% with a trading volume of 211,700 shares and a transaction value of 2.357 billion [1] - Kangtai Biological (300601) closed at 20.49, up 9.51% with a trading volume of 546,700 shares and a transaction value of 1.08 billion [1] Market Capital Flow - The biopharmaceutical sector saw a net inflow of 773 million from institutional investors, while retail investors experienced a net outflow of 328 million [2][3] - Major stocks like Changchun High-tech and Kangtai Biological had significant net inflows from institutional investors, indicating strong interest [3]